Trademark: 97096948
Word
PREDICTGEN
Status
Pending
Status Code
730
Status Date
Friday, May 10, 2024
Serial Number
97096948
Mark Type
4
Filing Date
Thursday, October 28, 2021
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Phenomics Health Inc. - Owner At Publication

Classifications
42 Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing analysis and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how an individual's genetic and non-genetic factors affect their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; scientific and technological services in the field of pharmaceuticals, namely, scientific testing, research, and analysis for the purpose of determining a patient's disease and drug response phenotype through evaluation of chromatin state, genomic regulatory elements, epigenomics, proteomics, metabolomics, transcriptomics, environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of buccal, saliva, blood and other biological samples for the purposes of supporting drug clinical trials and research into the field of new drug development and drug repurposing
PREDICT GEN

Trademark Events
Nov 1, 2021
New Application Entered
Nov 9, 2021
New Application Office Supplied Data Entered
Jul 5, 2022
Non-Final Action Written
Jun 15, 2022
Assigned To Examiner
Jul 5, 2022
Non-Final Action E-Mailed
Jul 5, 2022
Notification Of Non-Final Action E-Mailed
Jan 3, 2023
Teas Response To Office Action Received
Jan 3, 2023
Correspondence Received In Law Office
Jan 3, 2023
Teas/Email Correspondence Entered
Feb 1, 2023
Final Refusal Written
Feb 1, 2023
Final Refusal E-Mailed
Feb 1, 2023
Notification Of Final Refusal Emailed
Apr 27, 2023
Application Extension To Response Period - Received
Apr 27, 2023
Application Extension Granted/Receipt Provided
Jul 31, 2023
Exparte Appeal Received At Ttab
Jul 31, 2023
Jurisdiction Restored To Examining Attorney
Jul 31, 2023
Ex Parte Appeal-Instituted
Jul 31, 2023
Teas Request For Reconsideration Received
Aug 16, 2023
Correspondence Received In Law Office
Aug 16, 2023
Teas/Email Correspondence Entered
Aug 16, 2023
Approved For Pub - Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Published For Opposition
May 10, 2024
Sou Teas Extension Received
May 10, 2024
Sou Extension 1 Granted
May 10, 2024
Sou Extension 1 Filed
May 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24